BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15006605)

  • 1. Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia.
    Kiem HP; Sellers S; Thomasson B; Morris JC; Tisdale JF; Horn PA; Hematti P; Adler R; Kuramoto K; Calmels B; Bonifacino A; Hu J; von Kalle C; Schmidt M; Sorrentino B; Nienhuis A; Blau CA; Andrews RG; Donahue RE; Dunbar CE
    Mol Ther; 2004 Mar; 9(3):389-95. PubMed ID: 15006605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell gene transfer: insights into integration and hematopoiesis from primate genetic marking studies.
    Dunbar CE
    Ann N Y Acad Sci; 2005 Jun; 1044():178-82. PubMed ID: 15958711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.
    Calmels B; Ferguson C; Laukkanen MO; Adler R; Faulhaber M; Kim HJ; Sellers S; Hematti P; Schmidt M; von Kalle C; Akagi K; Donahue RE; Dunbar CE
    Blood; 2005 Oct; 106(7):2530-3. PubMed ID: 15933056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34+ cells.
    Kim YJ; Kim YS; Larochelle A; Renaud G; Wolfsberg TG; Adler R; Donahue RE; Hematti P; Hong BK; Roayaei J; Akagi K; Riberdy JM; Nienhuis AW; Dunbar CE; Persons DA
    Blood; 2009 May; 113(22):5434-43. PubMed ID: 19339698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates.
    Kim HJ; Tisdale JF; Wu T; Takatoku M; Sellers SE; Zickler P; Metzger ME; Agricola BA; Malley JD; Kato I; Donahue RE; Brown KE; Dunbar CE
    Blood; 2000 Jul; 96(1):1-8. PubMed ID: 10891424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial.
    Schmidt M; Hacein-Bey-Abina S; Wissler M; Carlier F; Lim A; Prinz C; Glimm H; Andre-Schmutz I; Hue C; Garrigue A; Le Deist F; Lagresle C; Fischer A; Cavazzana-Calvo M; von Kalle C
    Blood; 2005 Apr; 105(7):2699-706. PubMed ID: 15585650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods.
    Wu T; Kim HJ; Sellers SE; Meade KE; Agricola BA; Metzger ME; Kato I; Donahue RE; Dunbar CE; Tisdale JF
    Mol Ther; 2000 Mar; 1(3):285-93. PubMed ID: 10933944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.
    Hematti P; Hong BK; Ferguson C; Adler R; Hanawa H; Sellers S; Holt IE; Eckfeldt CE; Sharma Y; Schmidt M; von Kalle C; Persons DA; Billings EM; Verfaillie CM; Nienhuis AW; Wolfsberg TG; Dunbar CE; Calmels B
    PLoS Biol; 2004 Dec; 2(12):e423. PubMed ID: 15550989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro.
    Verhasselt B; De Smedt M; Verhelst R; Naessens E; Plum J
    Blood; 1998 Jan; 91(2):431-40. PubMed ID: 9427695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
    Qazilbash MH; Walsh CE; Russell SM; Noguchi M; Mann MM; Leonard WJ; Liu JM
    J Hematother; 1995 Apr; 4(2):91-8. PubMed ID: 7633846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells.
    Plavec I; Voytovich A; Moss K; Webster D; Hanley MB; Escaich S; Ho KE; Böhnlein E; DiGiusto DL
    Gene Ther; 1996 Aug; 3(8):717-24. PubMed ID: 8854097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM; Tisdale JF
    Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
    Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of the human interferon beta scaffold attachment region to retroviral vector backbones increases the level of in vivo transgene expression among progeny of engrafted human hematopoietic stem cells.
    Murray L; Travis M; Luens-Abitorabi K; Olsson K; Plavec I; Forestell S; Hanania EG; Hill B
    Hum Gene Ther; 2000 Sep; 11(14):2039-50. PubMed ID: 11020802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences among nonhuman primates in susceptibility to bone marrow progenitor transduction with retrovirus vectors.
    Emery DW; Andrews RG; Papayannopoulou T
    Gene Ther; 2000 Mar; 7(5):359-67. PubMed ID: 10694817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell.
    Li Z; Fehse B; Schiedlmeier B; Düllmann J; Frank O; Zander AR; Ostertag W; Baum C
    Leukemia; 2002 Sep; 16(9):1655-63. PubMed ID: 12200677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.
    Hanazono Y; Nagashima T; Takatoku M; Shibata H; Ageyama N; Asano T; Ueda Y; Dunbar CE; Kume A; Terao K; Hasegawa M; Ozawa K
    Gene Ther; 2002 Aug; 9(16):1055-64. PubMed ID: 12140733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.